Advertisement
Research Article

Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis

  • Piero Olliaro mail,

    olliarop@who.int

    Affiliations: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland, Centre for Tropical Medicine and Vaccinology, Nuffield Department of Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

    X
  • Michel Vaillant,

    Affiliation: Competence Centre for Methodology and Statistics, Centre de Recherche Public – Santé (CRP-Santé), Luxembourg, Grand Duchy of Luxembourg

    X
  • Byron Arana,

    Affiliation: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland

    X
  • Max Grogl,

    Affiliation: Walter Reed Army Institute of Research (WRAIR) Division of Experimental Therapeutics, Silver Spring, Maryland, United States of America

    X
  • Farrokh Modabber,

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X
  • Alan Magill,

    Affiliation: Walter Reed Army Institute of Research (WRAIR) Division of Experimental Therapeutics, Silver Spring, Maryland, United States of America

    X
  • Olivier Lapujade,

    Affiliation: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland

    X
  • Pierre Buffet,

    Affiliation: UMR945, University Pierre & Marie Curie, Paris, France & Department of Parasitology, Pitié-Salpêtrière Hospital, APHP, Paris, France

    X
  • Jorge Alvar

    Affiliation: World Health Organization, Neglected Tropical Diseases (WHO/NTD), Geneva, Switzerland

    X
  • Published: March 21, 2013
  • DOI: 10.1371/journal.pntd.0002130

Reader Comments (0)

Post a new comment on this article